Onderzoeksoutput

Onderzoeksoutput per jaar 2021 2022 2023 2023

• 71 Citaties
• 3 h-index
• 5 Article
• 1 Poster

Onderzoeksoutput per jaar

Onderzoeksoutput per jaar

Zoekresultaten

• 2023

  Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models

  Clappaert, E., Kancheva, D., Debraekeleer, A., Brughmans, J., Bardet, P., Elkrim, Y., Lacroix, D., Zivalj, M., Hamouda, A. E. I., Van Ginderachter, J., Deschoemaeker, S. & Laoui, D., 16 okt 2023.

  Onderzoeksoutput: Poster

• Flt3L therapy increases the abundance of Treg-promoting CCR7⁺ cDCs in preclinical cancer models

  Clappaert, E. J., Kancheva, D., Brughmans, J., Debraekeleer, A., Bardet, P. M. R., Elkrim, Y., Lacroix, D., Živalj, M., Hamouda, A. E. I., Van Ginderachter, J. A., Deschoemaeker, S. & Laoui, D., 2023, In: Frontiers in Immunology. 14, 11 blz., 1166180.

  Onderzoeksoutput: Article › peer review

  Open Access
  3 Citaten (Scopus)

• Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models

  Clappaert, E. J., Kancheva, D., Brughmans, J., Debraekeleer, A., Bardet, P. M. R., Elkrim, Y., Lacroix, D., Živalj, M., Hamouda, A. E. I., Van Ginderachter, J. A., Deschoemaeker, S. & Laoui, D., 9 aug 2023, In: Frontiers in Immunology. 14, 1166180.

  Onderzoeksoutput: Article › peer review

  Open Access

  Bestand

  • Dendritic Cells 100%
  • Neoplasms 36%
  • Phenotype 20%
  • Therapeutics 18%
  • Lung Neoplasms 17%
  3 Citaten (Scopus)

  24 Downloads (Pure)
• 2022

  Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

  Murgaski, A., Kiss, M., Van Damme, H., Kancheva, D., Vanmeerbeek, I., Keirsse, J., Hadadi, E., Brughmans, J., Arnouk, S. M., Hamouda, A. E. I., Debraekeleer, A., Bosteels, V., Elkrim, Y., Boon, L., Hoves, S., Vandamme, N., Deschoemaeker, S., Janssens, S., Garg, A. D., Velde, G. V. & 3 anderen, Schmittnaegel, M., Ries, C. H. & Laoui, D., 15 okt 2022, In: Cancer Research. 82, 20, blz. 3785-3801 17 blz.

  Onderzoeksoutput: Article › peer review

  Open Access

  Bestand

  • Macrophages 100%
  • Neoplasms 30%
  • Immunogenic Cell Death 25%
  • Therapeutics 23%
  • T-Lymphocytes 19%
  14 Citaten (Scopus)

  41 Downloads (Pure)

• Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment

  Kiss, M., Lebegge, E., Murgaski, A., Van Damme, H., Kancheva, D., Brughmans, J., Scheyltjens, I., Talebi, A., Awad, R. M., Elkrim, Y., Bardet, P. M. R., Arnouk, S. M., Goyvaerts, C., Swinnen, J., Nana, F. A., Van Ginderachter, J. A. & Laoui, D., 1 dec 2022, In: Frontiers in Immunology. 13, 14 blz., 1003975.

  Onderzoeksoutput: Article › peer review

  Open Access

  • Junctional Adhesion Molecule A 100%
  • Tumor Microenvironment 59%
  • Myeloid Cells 58%
  • Inflammation 19%
  • Neoplasms 15%
  2 Citaten (Scopus)
• 2021

  IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D

  Kiss, M., Vande Walle, L., Saavedra, P. H. V., Lebegge, E., Van Damme, H., Murgaski, A., Qian, J., Ehling, M., Pretto, S., Bolli, E., Keirsse, J., Bardet, P. M. R., Arnouk, S. M., Elkrim, Y., Schmoetten, M., Brughmans, J., Debraekeleer, A., Fossoul, A., Boon, L., Raes, G. & 8 anderen, van Loo, G., Lambrechts, D., Mazzone, M., Beschin, A., Wullaert, A., Lamkanfi, M., Van Ginderachter, J. A. & Laoui, D., mrt 2021, In: Cancer Immunology Research. 9, 3, blz. 309-323 15 blz.

  Onderzoeksoutput: Article › peer review

  Open Access

  Bestand

  • Inflammasomes 100%
  • Tumor Microenvironment 86%
  • Neoplasms 26%
  • T-Lymphocytes 25%
  • Macrophages 21%
  49 Citaten (Scopus)

  168 Downloads (Pure)